Pharmacologic Actions: News and Research on Hydroxymethylglutaryl-CoA Reductase Inhibitors

MeSH tree: D27.505.519.389.370

Study finds ALS drug hope via AI and veteran records

A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified several existing medications ...

Cholesterol crystals may trigger some liver disease

Cholesterol crystals in the liver may stiffen the organ early in those with metabolic dysfunction-associated steatotic liver disease (MASLD)—well before scarring develops—according to new research from a team in the Perelman ...

Experimental pill dramatically reduces 'bad' cholesterol

An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" cholesterol, by up to 60%, according to a new phase three clinical trial published in the New England ...

Statins emerge as potential cancer immunotherapy boosters

Cancer immunotherapy has transformed modern oncology by harnessing the body's own immune system to combat malignant disease. Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have produced durable responses in ...

page 1 from 15